Kenvue Misses Estimates as Inflation, Tariffs Squeeze Margins
The US consumer health company and parent of Neutrogena narrowly missed Wall Street estimates for second-quarter results as tariffs and currency-related costs offset sales gains.
We haven't written up this one. Business of Fashion has the full story — the link below goes straight to it.